Clinical Trials Directory

Trials / Unknown

UnknownNCT04022655

Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit

Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit - Retrospective Analysis at a Single Tertiary Care Center

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of Göttingen · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, myositis, or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, may affect multiple organ systems. Occasionally, patients deteriorate acutely requiring advanced care in an intensive care unit (ICU). In an ICU setting, mortality is estimated with scoring systems, such as APACHE or SAPSII. Since there are limited data available on their use in autoimmune diseases, with the current study, we aim to assess the usefulness of these ICU scores and analyze predictors of mortality in this particular group of patients.

Conditions

Interventions

TypeNameDescription
OTHERICU CareNo intervention

Timeline

Start date
2019-07-22
Primary completion
2019-08-01
Completion
2019-10-01
First posted
2019-07-17
Last updated
2019-07-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04022655. Inclusion in this directory is not an endorsement.